JNJJOHNSON & JOHNSON
- Market cap
- $635.07B
- as of 2026-10-23
- Latest close
- $263.81
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Drug Manufacturers - General
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-12-07
Dashed line = amended filing (Form 4/A)
Showing the latest 500 of 650 transactions.
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Hewson Marillyn A | Sep 8 | Sep 10 | A · derivative | 180.96 | $276.31 | $50,001 | 16,049.42 | No | Form 4 |
| Woods Eugene A. | Sep 8 | Sep 10 | A · derivative | 135.72 | $276.31 | $37,501 | 6,578.77 | No | Form 4 |
| Pinto Daniel E | Sep 8 | Sep 10 | A · derivative | 113.1 | $276.31 | $31,251 | 2,445.18 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Sep 2 | Sep 4 | M | 11,070 | $131.94 | $1,460,576 | 36,517 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Sep 2 | Sep 4 | S | 11,070 | $274.74 | Sale −$3,041,372 | 25,447 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Sep 2 | Sep 4 | M | 22,527 | $151.41 | $3,410,813 | 47,974 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Sep 2 | Sep 4 | S | 22,527 | $274.74 | Sale −$6,189,068 | 25,447 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Sep 2 | Sep 4 | M · derivative | 11,070 | $131.94 | $1,460,576 | not reported | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Sep 2 | Sep 4 | M · derivative | 22,527 | $151.41 | $3,410,813 | not reported | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Aug 17 | Aug 18 | M | 15,000 | $115.67 | $1,735,050 | 209,451 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Aug 17 | Aug 18 | S | 15,000 | $263.36 | Sale −$3,950,400 | 194,451 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Aug 17 | Aug 18 | M · derivative | 15,000 | $115.67 | $1,735,050 | 28,712 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Aug 13 | Aug 14 | M | 123,291 | $115.67 | $14,261,070 | 399,258 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Aug 13 | Aug 14 | S | 20,976 | $262.00 | Sale −$5,495,712 | 378,282 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Aug 13 | Aug 14 | S | 102,315 | $261.00 | Sale −$26,704,215 | 275,967 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Aug 13 | Aug 14 | M · derivative | 123,291 | $115.67 | $14,261,070 | not reported | No | Form 4 |
| Forminard ElizabethEVP, Chief Legal Officer | Aug 6 | Aug 7 | M | 9,344 | $131.94 | $1,232,847 | 32,912 | No | Form 4 |
| Forminard ElizabethEVP, Chief Legal Officer | Aug 6 | Aug 7 | S | 9,344 | $257.76 | Sale −$2,408,509 | 23,568 | No | Form 4 |
| Forminard ElizabethEVP, Chief Legal Officer | Aug 6 | Aug 7 | S | 6,574 | $255.93 | Sale −$1,682,484 | 16,994 | No | Form 4 |
| Forminard ElizabethEVP, Chief Legal Officer | Aug 6 | Aug 7 | M · derivative | 9,344 | $131.94 | $1,232,847 | not reported | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Aug 5 | Aug 7 | S | 41,957 | $258.06 | Sale −$10,827,423 | 282,490 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Aug 5 | Aug 7 | S | 6,523 | $258.74 | Sale −$1,687,761 | 275,967 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Jul 20 | Jul 21 | M | 11,129 | $129.51 | $1,441,317 | 34,132 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Jul 20 | Jul 21 | M | 11,925 | $131.94 | $1,573,385 | 46,057 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Jul 20 | Jul 21 | S | 23,054 | $251.27 | Sale −$5,792,779 | 23,003 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Jul 20 | Jul 21 | M · derivative | 11,129 | $129.51 | $1,441,317 | not reported | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Jul 20 | Jul 21 | M · derivative | 11,925 | $131.94 | $1,573,385 | not reported | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Jun 11 | Jun 12 | M | 10,000 | $115.67 | $1,156,700 | 124,287.87 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Jun 11 | Jun 12 | S | 10,000 | $241.15 | Sale −$2,411,500 | 114,287.87 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Jun 11 | Jun 12 | M · derivative | 10,000 | $115.67 | $1,156,700 | 32,965 | No | Form 4 |
| Hewson Marillyn A | Jun 9 | Jun 11 | A · derivative | 214.79 | $232.79 | $50,001 | 15,791.88 | No | Form 4 |
| Pinto Daniel E | Jun 9 | Jun 11 | A · derivative | 134.24 | $232.79 | $31,250 | 2,320.82 | No | Form 4 |
| Woods Eugene A. | Jun 9 | Jun 11 | A · derivative | 161.09 | $232.79 | $37,500 | 6,411.96 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | May 1 | May 4 | M | 25,255 | $0.00 | $0 | 35,913 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | May 1 | May 4 | F | 11,002 | $229.85 | $2,528,810 | 24,911 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | May 1 | May 4 | M · derivative | 25,255 | $0.00 | $0 | not reported | No | Form 4 |
| Beckerle Mary C | Apr 23 | Apr 27 | A · derivative | 975 | $0.00 | $0 | 16,797.74 | No | Form 4 |
| Doudna Jennifer A | Apr 23 | Apr 27 | A · derivative | 975 | $0.00 | $0 | 10,899.17 | No | Form 4 |
| Hewson Marillyn A | Apr 23 | Apr 27 | A · derivative | 975 | $0.00 | $0 | 15,487.94 | No | Form 4 |
| Johnson Paula A | Apr 23 | Apr 27 | A · derivative | 975 | $0.00 | $0 | 5,359.4 | No | Form 4 |
| Joly Hubert | Apr 23 | Apr 27 | A · derivative | 975 | $0.00 | $0 | 9,183.61 | No | Form 4 |
| McClellan Mark B. | Apr 23 | Apr 27 | A · derivative | 975 | $0.00 | $0 | 21,278.59 | No | Form 4 |
| Morikis John G | Apr 23 | Apr 27 | A · derivative | 1,540 | $0.00 | $0 | 1,540 | No | Form 4 |
| Pinto Daniel E | Apr 23 | Apr 27 | A · derivative | 1,712 | $0.00 | $0 | 2,174.07 | No | Form 4 |
| Weinberger Mark A | Apr 23 | Apr 27 | A · derivative | 975 | $0.00 | $0 | 12,010.41 | No | Form 4 |
| West Nadja | Apr 23 | Apr 27 | A · derivative | 975 | $0.00 | $0 | 7,730.05 | No | Form 4 |
| Woods Eugene A. | Apr 23 | Apr 27 | A · derivative | 975 | $0.00 | $0 | 6,215.09 | No | Form 4 |
| Woods Eugene A. | Mar 10 | Mar 12 | A · derivative | 154.87 | $242.14 | $37,500 | 5,240.09 | No | Form 4 |
| Pinto Daniel E | Mar 10 | Mar 12 | A · derivative | 129.06 | $242.14 | $31,251 | 462.07 | No | Form 4 |
| Hewson Marillyn A | Mar 10 | Mar 12 | A · derivative | 206.49 | $242.14 | $49,999 | 14,512.94 | No | Form 4 |
| Hewson Marillyn A | Mar 4, 2025 | Mar 12 | A · derivative | 75.26 | $166.10 | $12,501 | 14,306.45 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 27 | Mar 3 | M | 4,075 | $115.67 | $471,355 | 27,757 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 27 | Mar 3 | S | 4,075 | $247.87 | Sale −$1,010,070 | 23,682 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 27 | Mar 3 | M · derivative | 4,075 | $115.67 | $471,355 | not reported | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 20 | Feb 23 | S | 1,322 | $245.66 | Sale −$324,763 | 25,447 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 18 | Feb 18 | M | 13,625 | $115.67 | $1,576,004 | 40,394 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 18 | Feb 18 | S | 13,625 | $244.20 | Sale −$3,327,225 | 26,769 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 18 | Feb 18 | M | 8,998 | $129.51 | $1,165,331 | 35,767 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 18 | Feb 18 | S | 8,998 | $244.53 | Sale −$2,200,281 | 26,769 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 18 | Feb 18 | M · derivative | 13,625 | $115.67 | $1,576,004 | not reported | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 18 | Feb 18 | M · derivative | 8,998 | $129.51 | $1,165,331 | not reported | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 17 | Feb 18 | S | 6,197 | $243.39 | Sale −$1,508,288 | 23,003 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | Feb 17 | Feb 18 | M | 21,721 | $157.92 | $3,430,180 | 34,662 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | Feb 17 | Feb 18 | S | 21,721 | $243.00 | Sale −$5,278,203 | 12,941 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | Feb 17 | Feb 18 | M | 29,927 | $156.15 | $4,673,101 | 42,868 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | Feb 17 | Feb 18 | S | 29,927 | $243.00 | Sale −$7,272,261 | 12,941 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | Feb 17 | Feb 18 | S | 2,283 | $243.00 | Sale −$554,769 | 10,658 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | Feb 17 | Feb 18 | M · derivative | 21,721 | $157.92 | $3,430,180 | 21,721 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | Feb 17 | Feb 18 | M · derivative | 29,927 | $156.15 | $4,673,101 | 59,854 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 17 | Feb 18 | M | 19,241 | $115.67 | $2,225,606 | 58,202 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 17 | Feb 18 | S | 19,241 | $242.99 | Sale −$4,675,371 | 38,961 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 17 | Feb 18 | M | 12,066 | $129.51 | $1,562,668 | 51,027 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 17 | Feb 18 | S | 12,066 | $242.87 | Sale −$2,930,469 | 38,961 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 17 | Feb 18 | M | 33,386 | $131.94 | $4,404,949 | 72,347 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 17 | Feb 18 | S | 33,386 | $242.75 | Sale −$8,104,452 | 38,961 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 17 | Feb 18 | S | 24,961 | $242.68 | Sale −$6,057,535 | 14,000 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 17 | Feb 18 | M · derivative | 19,241 | $115.67 | $2,225,606 | not reported | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 17 | Feb 18 | M · derivative | 12,066 | $129.51 | $1,562,668 | not reported | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 17 | Feb 18 | M · derivative | 33,386 | $131.94 | $4,404,949 | 33,000 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 17 | Feb 18 | M | 20,521 | $164.62 | $3,378,167 | 46,219.13 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 17 | Feb 18 | S | 20,521 | $242.70 | Sale −$4,980,447 | 25,698.13 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 17 | Feb 18 | M · derivative | 20,521 | $164.62 | $3,378,167 | not reported | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 15 | Feb 18 | M | 492 | $0.00 | $0 | 29,196 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 15 | Feb 18 | F | 252 | $243.45 | $61,349 | 28,944 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 15 | Feb 18 | M | 526 | $0.00 | $0 | 29,470 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 15 | Feb 18 | F | 270 | $243.45 | $65,732 | 29,200 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 15 | Feb 18 | M · derivative | 492 | $0.00 | $0 | 491 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 15 | Feb 18 | M · derivative | 526 | $0.00 | $0 | 1,050 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 15 | Feb 18 | A · derivative | 14,405 | $243.45 | $3,506,897 | 14,405 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 15 | Feb 18 | A · derivative | 1,034 | $0.00 | $0 | 1,034 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 15 | Feb 18 | M | 3,682 | $0.00 | $0 | 323,504 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 15 | Feb 18 | F | 1,602 | $243.45 | $390,007 | 321,902 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 15 | Feb 18 | M | 4,505 | $0.00 | $0 | 326,407 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 15 | Feb 18 | F | 1,960 | $243.45 | $477,162 | 324,447 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 15 | Feb 18 | M · derivative | 3,682 | $0.00 | $0 | 3,682 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 15 | Feb 18 | M · derivative | 4,505 | $0.00 | $0 | 9,008 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 15 | Feb 18 | A · derivative | 131,734 | $243.45 | $32,070,642 | 131,734 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 15 | Feb 18 | A · derivative | 9,459 | $0.00 | $0 | 9,459 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 15 | Feb 18 | M | 1,028 | $0.00 | $0 | 26,206 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 15 | Feb 18 | F | 15 | $243.45 | $3,652 | 26,191 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 15 | Feb 18 | M | 1,026 | $0.00 | $0 | 27,217 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 15 | Feb 18 | F | 448 | $243.45 | $109,066 | 26,769 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 15 | Feb 18 | M · derivative | 1,028 | $0.00 | $0 | 1,028 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 15 | Feb 18 | M · derivative | 1,026 | $0.00 | $0 | 2,051 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 15 | Feb 18 | A · derivative | 35,489 | $243.45 | $8,639,797 | 35,489 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 15 | Feb 18 | A · derivative | 2,548 | $0.00 | $0 | 2,548 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 15 | Feb 18 | M | 1,594 | $0.00 | $0 | 194,365 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 15 | Feb 18 | F | 816 | $243.45 | $198,655 | 193,549 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 15 | Feb 18 | M | 1,847 | $0.00 | $0 | 195,396 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 15 | Feb 18 | F | 945 | $243.45 | $230,060 | 194,451 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 15 | Feb 18 | M · derivative | 1,594 | $0.00 | $0 | 1,594 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 15 | Feb 18 | M · derivative | 1,847 | $0.00 | $0 | 3,692 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 15 | Feb 18 | A · derivative | 54,869 | $243.45 | $13,357,858 | 54,869 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 15 | Feb 18 | A · derivative | 3,940 | $0.00 | $0 | 3,940 | No | Form 4 |
| Forminard ElizabethEVP, Chief Legal Officer | Feb 15 | Feb 18 | M | 961 | $0.00 | $0 | 23,541 | No | Form 4 |
| Forminard ElizabethEVP, Chief Legal Officer | Feb 15 | Feb 18 | F | 492 | $243.45 | $119,777 | 23,049 | No | Form 4 |
| Forminard ElizabethEVP, Chief Legal Officer | Feb 15 | Feb 18 | M | 1,063 | $0.00 | $0 | 24,112 | No | Form 4 |
| Forminard ElizabethEVP, Chief Legal Officer | Feb 15 | Feb 18 | F | 544 | $243.45 | $132,437 | 23,568 | No | Form 4 |
| Forminard ElizabethEVP, Chief Legal Officer | Feb 15 | Feb 18 | M · derivative | 961 | $0.00 | $0 | 961 | No | Form 4 |
| Forminard ElizabethEVP, Chief Legal Officer | Feb 15 | Feb 18 | M · derivative | 1,063 | $0.00 | $0 | 2,126 | No | Form 4 |
| Forminard ElizabethEVP, Chief Legal Officer | Feb 15 | Feb 18 | A · derivative | 27,076 | $243.45 | $6,591,652 | 27,076 | No | Form 4 |
| Forminard ElizabethEVP, Chief Legal Officer | Feb 15 | Feb 18 | A · derivative | 1,944 | $0.00 | $0 | 1,944 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | Feb 15 | Feb 18 | M | 1,349 | $0.00 | $0 | 12,007 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | Feb 15 | Feb 18 | F | 385 | $243.45 | $93,728 | 11,622 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | Feb 15 | Feb 18 | M | 1,847 | $0.00 | $0 | 13,469 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | Feb 15 | Feb 18 | F | 528 | $243.45 | $128,542 | 12,941 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | Feb 15 | Feb 18 | M · derivative | 1,349 | $0.00 | $0 | 1,349 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | Feb 15 | Feb 18 | M · derivative | 1,847 | $0.00 | $0 | 3,692 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | Feb 15 | Feb 18 | A · derivative | 49,382 | $243.45 | $12,022,048 | 49,382 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | Feb 15 | Feb 18 | A · derivative | 3,546 | $0.00 | $0 | 3,546 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 15 | Feb 18 | M | 339 | $0.00 | $0 | 23,527 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 15 | Feb 18 | F | 94 | $243.45 | $22,884 | 23,433 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 15 | Feb 18 | M | 344 | $0.00 | $0 | 23,777 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 15 | Feb 18 | F | 95 | $243.45 | $23,128 | 23,682 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 15 | Feb 18 | M · derivative | 339 | $0.00 | $0 | 338 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 15 | Feb 18 | M · derivative | 344 | $0.00 | $0 | 687 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 15 | Feb 18 | A · derivative | 4,871 | $243.45 | $1,185,845 | 4,871 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 15 | Feb 18 | A · derivative | 700 | $0.00 | $0 | 700 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 15 | Feb 18 | M | 1,971 | $0.00 | $0 | 38,758 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 15 | Feb 18 | F | 858 | $243.45 | $208,880 | 37,900 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 15 | Feb 18 | M | 1,878 | $0.00 | $0 | 39,778 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 15 | Feb 18 | F | 817 | $243.45 | $198,899 | 38,961 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 15 | Feb 18 | M · derivative | 1,971 | $0.00 | $0 | 1,971 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 15 | Feb 18 | M · derivative | 1,878 | $0.00 | $0 | 3,754 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 15 | Feb 18 | A · derivative | 53,793 | $243.45 | $13,095,906 | 53,793 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 15 | Feb 18 | A · derivative | 3,863 | $0.00 | $0 | 3,863 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 15 | Feb 18 | M | 419 | $0.00 | $0 | 19,678 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 15 | Feb 18 | F | 172 | $243.45 | $41,873 | 19,506 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 15 | Feb 18 | M | 575 | $0.00 | $0 | 20,081 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 15 | Feb 18 | F | 251 | $243.45 | $61,106 | 19,830 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 15 | Feb 18 | M · derivative | 419 | $0.00 | $0 | 418 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 15 | Feb 18 | M · derivative | 575 | $0.00 | $0 | 1,150 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 15 | Feb 18 | A · derivative | 20,322 | $243.45 | $4,947,391 | 20,322 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 15 | Feb 18 | A · derivative | 1,459 | $0.00 | $0 | 1,459 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 15 | Feb 18 | M | 606 | $0.00 | $0 | 114,287.87 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 15 | Feb 18 | F | 310 | $243.45 | $75,470 | 113,977.87 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 15 | Feb 18 | M | 635 | $0.00 | $0 | 114,612.87 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 15 | Feb 18 | F | 325 | $243.45 | $79,121 | 114,287.87 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 15 | Feb 18 | M · derivative | 606 | $0.00 | $0 | 606 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 15 | Feb 18 | M · derivative | 635 | $0.00 | $0 | 1,268 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 15 | Feb 18 | A · derivative | 16,945 | $243.45 | $4,125,260 | 16,945 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 15 | Feb 18 | A · derivative | 1,217 | $0.00 | $0 | 1,217 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 15 | Feb 18 | M | 492 | $0.00 | $0 | 25,512.13 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 15 | Feb 18 | F | 214 | $243.45 | $52,098 | 25,298.13 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 15 | Feb 18 | M | 709 | $0.00 | $0 | 26,007.13 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 15 | Feb 18 | F | 309 | $243.45 | $75,226 | 25,698.13 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 15 | Feb 18 | M · derivative | 492 | $0.00 | $0 | 491 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 15 | Feb 18 | M · derivative | 709 | $0.00 | $0 | 1,418 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 15 | Feb 18 | A · derivative | 19,449 | $243.45 | $4,734,859 | 19,449 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 15 | Feb 18 | A · derivative | 1,397 | $0.00 | $0 | 1,397 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 13 | Feb 18 | M | 408 | $0.00 | $0 | 24,002 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 13 | Feb 18 | F | 144 | $244.55 | $35,215 | 23,858 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 13 | Feb 18 | M | 8,594 | $0.00 | $0 | 32,452 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 13 | Feb 18 | F | 3,748 | $244.55 | $916,573 | 28,704 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 13 | Feb 18 | M · derivative | 408 | $0.00 | $0 | not reported | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 13 | Feb 18 | M · derivative | 8,594 | $0.00 | $0 | not reported | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 13 | Feb 18 | M | 3,469 | $0.00 | $0 | 279,436 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 13 | Feb 18 | F | 989 | $244.55 | $241,860 | 278,447 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 13 | Feb 18 | M | 73,054 | $0.00 | $0 | 351,501 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 13 | Feb 18 | F | 31,679 | $244.55 | $7,747,099 | 319,822 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 13 | Feb 18 | M · derivative | 3,469 | $0.00 | $0 | not reported | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 13 | Feb 18 | M · derivative | 73,054 | $0.00 | $0 | not reported | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 13 | Feb 18 | M | 499 | $0.00 | $0 | 22,624 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 13 | Feb 18 | F | 8 | $244.55 | $1,956 | 22,616 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 13 | Feb 18 | M | 4,378 | $0.00 | $0 | 26,994 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 13 | Feb 18 | F | 1,816 | $244.55 | $444,103 | 25,178 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 13 | Feb 18 | M · derivative | 499 | $0.00 | $0 | not reported | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 13 | Feb 18 | M · derivative | 4,378 | $0.00 | $0 | not reported | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 13 | Feb 18 | M | 1,302 | $0.00 | $0 | 179,315 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 13 | Feb 18 | F | 409 | $244.55 | $100,021 | 178,906 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 13 | Feb 18 | M | 27,412 | $0.00 | $0 | 206,318 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 13 | Feb 18 | F | 13,547 | $244.55 | $3,312,919 | 192,771 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 13 | Feb 18 | M · derivative | 1,302 | $0.00 | $0 | not reported | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 13 | Feb 18 | M · derivative | 27,412 | $0.00 | $0 | not reported | No | Form 4 |
| Forminard ElizabethEVP, Chief Legal Officer | Feb 13 | Feb 18 | M | 651 | $0.00 | $0 | 16,199 | No | Form 4 |
| Forminard ElizabethEVP, Chief Legal Officer | Feb 13 | Feb 18 | F | 314 | $244.55 | $76,789 | 15,885 | No | Form 4 |
| Forminard ElizabethEVP, Chief Legal Officer | Feb 13 | Feb 18 | M | 13,706 | $0.00 | $0 | 29,591 | No | Form 4 |
| Forminard ElizabethEVP, Chief Legal Officer | Feb 13 | Feb 18 | F | 7,011 | $244.55 | $1,714,540 | 22,580 | No | Form 4 |
| Forminard ElizabethEVP, Chief Legal Officer | Feb 13 | Feb 18 | M · derivative | 651 | $0.00 | $0 | not reported | No | Form 4 |
| Forminard ElizabethEVP, Chief Legal Officer | Feb 13 | Feb 18 | M · derivative | 13,706 | $0.00 | $0 | not reported | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 13 | Feb 18 | M | 312 | $0.00 | $0 | 21,313 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 13 | Feb 18 | F | 104 | $244.55 | $25,433 | 21,209 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 13 | Feb 18 | M | 2,741 | $0.00 | $0 | 23,950 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 13 | Feb 18 | F | 762 | $244.55 | $186,347 | 23,188 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 13 | Feb 18 | M · derivative | 312 | $0.00 | $0 | not reported | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 13 | Feb 18 | M · derivative | 2,741 | $0.00 | $0 | not reported | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 13 | Feb 18 | M | 37,463 | $0.00 | $0 | 51,463 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 13 | Feb 18 | F | 15,948 | $244.55 | $3,900,083 | 35,515 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 13 | Feb 18 | M | 1,779 | $0.00 | $0 | 37,294 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 13 | Feb 18 | F | 507 | $244.55 | $123,987 | 36,787 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 13 | Feb 18 | M · derivative | 37,463 | $0.00 | $0 | not reported | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 13 | Feb 18 | M · derivative | 1,779 | $0.00 | $0 | not reported | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 13 | Feb 18 | M | 410 | $0.00 | $0 | 16,819 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 13 | Feb 18 | F | 135 | $244.55 | $33,014 | 16,684 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 13 | Feb 18 | M | 3,602 | $0.00 | $0 | 20,286 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 13 | Feb 18 | F | 1,027 | $244.55 | $251,153 | 19,259 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 13 | Feb 18 | M · derivative | 410 | $0.00 | $0 | not reported | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 13 | Feb 18 | M · derivative | 3,602 | $0.00 | $0 | not reported | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 13 | Feb 18 | M | 651 | $0.00 | $0 | 106,606.87 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 13 | Feb 18 | F | 217 | $244.55 | $53,067 | 106,389.87 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 13 | Feb 18 | M | 13,706 | $0.00 | $0 | 120,095.87 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 13 | Feb 18 | F | 6,414 | $244.55 | $1,568,544 | 113,681.87 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 13 | Feb 18 | M · derivative | 651 | $0.00 | $0 | not reported | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 13 | Feb 18 | M · derivative | 13,706 | $0.00 | $0 | not reported | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 13 | Feb 18 | M | 447 | $0.00 | $0 | 19,298.13 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 13 | Feb 18 | F | 143 | $244.55 | $34,971 | 19,155.13 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 13 | Feb 18 | M | 9,412 | $0.00 | $0 | 28,567.13 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 13 | Feb 18 | F | 3,547 | $244.55 | $867,419 | 25,020.13 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 13 | Feb 18 | M | 19,368 | $165.89 | $3,212,958 | 44,388.13 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 13 | Feb 18 | S | 19,368 | $243.76 | Sale −$4,721,144 | 25,020.13 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 13 | Feb 18 | M | 22,191 | $162.75 | $3,611,585 | 47,211.13 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 13 | Feb 18 | S | 22,191 | $243.71 | Sale −$5,408,169 | 25,020.13 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 13 | Feb 18 | M · derivative | 447 | $0.00 | $0 | not reported | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 13 | Feb 18 | M · derivative | 9,412 | $0.00 | $0 | not reported | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 13 | Feb 18 | M · derivative | 19,368 | $165.89 | $3,212,958 | not reported | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 13 | Feb 18 | M · derivative | 22,191 | $162.75 | $3,611,585 | not reported | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 9 | Feb 11 | A · derivative | 8,594 | $0.00 | $0 | 8,594 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 9 | Feb 11 | A · derivative | 13,706 | $0.00 | $0 | 13,706 | No | Form 4 |
| Forminard ElizabethEVP, Chief Legal Officer | Feb 9 | Feb 11 | A · derivative | 13,706 | $0.00 | $0 | 13,706 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 9 | Feb 11 | A · derivative | 3,602 | $0.00 | $0 | 3,602 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 9 | Feb 11 | A · derivative | 4,378 | $0.00 | $0 | 4,378 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 9 | Feb 11 | A · derivative | 9,412 | $0.00 | $0 | 9,412 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 9 | Feb 11 | A · derivative | 27,412 | $0.00 | $0 | 27,412 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 9 | Feb 11 | A · derivative | 37,463 | $0.00 | $0 | 37,463 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 9 | Feb 11 | A · derivative | 73,054 | $0.00 | $0 | 73,054 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 9 | Feb 11 | A · derivative | 2,741 | $0.00 | $0 | 2,741 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 6 | Feb 10 | M | 15,571 | $101.87 | $1,586,218 | 32,460 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 6 | Feb 10 | F | 10,335 | $239.99 | $2,480,297 | 22,125 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 6 | Feb 10 | M · derivative | 15,571 | $101.87 | $1,586,218 | not reported | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 6 | Feb 9 | M | 38,945 | $101.87 | $3,967,327 | 133,225.87 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 6 | Feb 9 | F | 27,270 | $239.99 | $6,544,527 | 105,955.87 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 6 | Feb 9 | M · derivative | 38,945 | $101.87 | $3,967,327 | not reported | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 6 | Feb 9 | M | 5,625 | $101.87 | $573,019 | 19,744 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 6 | Feb 9 | F | 3,335 | $239.99 | $800,367 | 16,409 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 6 | Feb 9 | M · derivative | 5,625 | $101.87 | $573,019 | not reported | No | Form 4 |
| Forminard ElizabethEVP, Chief Legal Officer | Feb 5 | Feb 6 | M | 8,921 | $129.51 | $1,155,359 | 21,774 | No | Form 4 |
| Forminard ElizabethEVP, Chief Legal Officer | Feb 5 | Feb 6 | F | 6,226 | $237.90 | $1,481,165 | 15,548 | No | Form 4 |
| Forminard ElizabethEVP, Chief Legal Officer | Feb 5 | Feb 6 | M · derivative | 8,921 | $129.51 | $1,155,359 | not reported | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Jan 26 | Jan 28 | S | 51,218 | $220.99 | Sale −$11,318,666 | 79,634 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Jan 26 | Jan 28 | S | 48,782 | $221.48 | Sale −$10,804,237 | 30,852 | No | Form 4 |
| Pinto Daniel E | Dec 9, 2025 | Dec 11, 2025 | A · derivative | 154.61 | $202.12 | $31,250 | 331.23 | No | Form 4 |
| Hewson Marillyn A | Dec 9, 2025 | Dec 11, 2025 | A · derivative | 247.38 | $202.12 | $50,000 | 14,153.12 | No | Form 4 |
| Woods Eugene A. | Dec 9, 2025 | Dec 11, 2025 | A · derivative | 185.53 | $202.12 | $37,499 | 5,058.07 | No | Form 4 |
| Morikis John G | Nov 26, 2025 | Dec 1, 2025 | P | 1,250 | $206.15 | Purchase +$257,688 | 1,848.51 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | Oct 17, 2025 | Oct 20, 2025 | M | 21,721 | $157.92 | $3,430,180 | 32,379 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | Oct 17, 2025 | Oct 20, 2025 | S | 21,721 | $192.71 | Sale −$4,185,854 | 10,658 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | Oct 17, 2025 | Oct 20, 2025 | M · derivative | 21,721 | $157.92 | $3,430,180 | 43,442 | No | Form 4 |
| Woods Eugene A. | Sep 9, 2025 | Sep 11, 2025 | A · derivative | 210.59 | $178.07 | $37,500 | 4,841.4 | No | Form 4 |
| Pinto Daniel E | Sep 9, 2025 | Sep 11, 2025 | A · derivative | 175.49 | $178.07 | $31,250 | 175.49 | No | Form 4 |
| Hewson Marillyn A | Sep 9, 2025 | Sep 11, 2025 | A · derivative | 280.79 | $178.07 | $50,000 | 13,816.87 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Sep 4, 2025 | Sep 5, 2025 | M | 56,471 | $101.87 | $5,752,701 | 234,484 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Sep 4, 2025 | Sep 5, 2025 | S | 56,471 | $177.81 | Sale −$10,041,109 | 178,013 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Sep 4, 2025 | Sep 5, 2025 | M · derivative | 56,471 | $101.87 | $5,752,701 | not reported | No | Form 4 |
| Forminard ElizabethExecutive VP, General Counsel | Aug 29, 2025 | Sep 3, 2025 | M | 11,521 | $115.67 | $1,332,634 | 22,423 | No | Form 4 |
| Forminard ElizabethExecutive VP, General Counsel | Aug 29, 2025 | Sep 3, 2025 | F | 9,570 | $177.20 | $1,695,804 | 12,853 | No | Form 4 |
| Forminard ElizabethExecutive VP, General Counsel | Aug 29, 2025 | Sep 3, 2025 | M · derivative | 11,521 | $115.67 | $1,332,634 | not reported | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Aug 22, 2025 | Aug 25, 2025 | M | 125,824 | $101.87 | $12,817,691 | 401,791 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Aug 22, 2025 | Aug 25, 2025 | S | 125,824 | $179.21 | Sale −$22,548,919 | 275,967 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Aug 22, 2025 | Aug 25, 2025 | M · derivative | 125,824 | $101.87 | $12,817,691 | not reported | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Aug 15, 2025 | Aug 18, 2025 | M | 16,820 | $101.87 | $1,713,453 | 30,820 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Aug 15, 2025 | Aug 18, 2025 | S | 16,820 | $176.91 | Sale −$2,975,626 | 14,000 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Aug 15, 2025 | Aug 18, 2025 | M · derivative | 16,820 | $101.87 | $1,713,453 | not reported | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | Jul 17, 2025 | Jul 18, 2025 | S | 19,137 | $163.55 | Sale −$3,129,856 | 10,658 | No | Form 4 |
| Woods Eugene A. | Jun 10, 2025 | Jun 12, 2025 | A · derivative | 231.32 | $155.23 | $35,908 | 4,597.24 | No | Form 4 |
| Hewson Marillyn A | Jun 10, 2025 | Jun 12, 2025 | A · derivative | 322.1 | $155.23 | $50,000 | 13,437.98 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | May 1, 2025 | May 5, 2025 | M | 25,255 | $0.00 | $0 | 40,797 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | May 1, 2025 | May 5, 2025 | F | 11,002 | $156.31 | $1,719,723 | 29,795 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | May 1, 2025 | May 5, 2025 | M · derivative | 25,255 | $0.00 | $0 | 25,255 | No | Form 4 |
| Doudna Jennifer A | Apr 24, 2025 | Apr 28, 2025 | A · derivative | 1,316 | $0.00 | $0 | 9,656.14 | No | Form 4 |
| Beckerle Mary C | Apr 24, 2025 | Apr 28, 2025 | A · derivative | 1,316 | $0.00 | $0 | 15,395.4 | No | Form 4 |
| Hewson Marillyn A | Apr 24, 2025 | Apr 28, 2025 | A · derivative | 1,316 | $0.00 | $0 | 13,006.95 | No | Form 4 |
| Johnson Paula A | Apr 24, 2025 | Apr 28, 2025 | A · derivative | 1,316 | $0.00 | $0 | 4,265.98 | No | Form 4 |
| Joly Hubert | Apr 24, 2025 | Apr 28, 2025 | A · derivative | 1,316 | $0.00 | $0 | 7,986.91 | No | Form 4 |
| McClellan Mark B. | Apr 24, 2025 | Apr 28, 2025 | A · derivative | 1,316 | $0.00 | $0 | 19,755.23 | No | Form 4 |
| Weinberger Mark A | Apr 24, 2025 | Apr 28, 2025 | A · derivative | 1,316 | $0.00 | $0 | 10,737.36 | No | Form 4 |
| West Nadja | Apr 24, 2025 | Apr 28, 2025 | A · derivative | 1,316 | $0.00 | $0 | 6,572.61 | No | Form 4 |
| Woods Eugene A. | Apr 24, 2025 | Apr 28, 2025 | A · derivative | 1,316 | $0.00 | $0 | 4,329.66 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Mar 18, 2025 | Mar 19, 2025 | G | 130,852 | $0.00 | $0 | 275,967 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Mar 18, 2025 | Mar 19, 2025 | G | 130,852 | $0.00 | $0 | 130,852 | No | Form 4 |
| Woods Eugene A. | Mar 4, 2025 | Mar 6, 2025 | A · derivative | 188.14 | $166.10 | $31,250 | 3,013.66 | No | Form 4 |
| Hewson Marillyn A | Mar 4, 2025 | Mar 6, 2025 | A · derivative | 225.77 | $166.10 | $37,500 | 11,690.95 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 25, 2025 | Feb 26, 2025 | M | 6,999 | $101.87 | $712,988 | 28,000 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 25, 2025 | Feb 26, 2025 | S | 6,999 | $165.88 | Sale −$1,160,994 | 21,001 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 25, 2025 | Feb 26, 2025 | M · derivative | 6,999 | $101.87 | $712,988 | not reported | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 15, 2025 | Feb 19, 2025 | A · derivative | 25,538 | $156.15 | $3,987,759 | 25,538 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 15, 2025 | Feb 19, 2025 | A · derivative | 1,576 | $0.00 | $0 | 1,576 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 15, 2025 | Feb 19, 2025 | A · derivative | 219,020 | $156.15 | $34,199,973 | 219,020 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 15, 2025 | Feb 19, 2025 | A · derivative | 13,513 | $0.00 | $0 | 13,513 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 15, 2025 | Feb 19, 2025 | A · derivative | 8,357 | $156.15 | $1,304,946 | 8,357 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 15, 2025 | Feb 19, 2025 | A · derivative | 1,031 | $0.00 | $0 | 1,031 | No | Form 4 |
| Forminard ElizabethExecutive VP, General Counsel | Feb 15, 2025 | Feb 19, 2025 | A · derivative | 51,688 | $156.15 | $8,071,081 | 51,688 | No | Form 4 |
| Forminard ElizabethExecutive VP, General Counsel | Feb 15, 2025 | Feb 19, 2025 | A · derivative | 3,189 | $0.00 | $0 | 3,189 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 15, 2025 | Feb 19, 2025 | A · derivative | 27,951 | $156.15 | $4,364,549 | 27,951 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 15, 2025 | Feb 19, 2025 | A · derivative | 1,725 | $0.00 | $0 | 1,725 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | Feb 15, 2025 | Feb 19, 2025 | A · derivative | 89,781 | $156.15 | $14,019,303 | 89,781 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | Feb 15, 2025 | Feb 19, 2025 | A · derivative | 5,539 | $0.00 | $0 | 5,539 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 15, 2025 | Feb 19, 2025 | A · derivative | 49,878 | $156.15 | $7,788,450 | 49,878 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 15, 2025 | Feb 19, 2025 | A · derivative | 3,077 | $0.00 | $0 | 3,077 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 15, 2025 | Feb 19, 2025 | A · derivative | 34,476 | $156.15 | $5,383,427 | 34,476 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 15, 2025 | Feb 19, 2025 | A · derivative | 2,127 | $0.00 | $0 | 2,127 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 15, 2025 | Feb 19, 2025 | A · derivative | 89,781 | $156.15 | $14,019,303 | 89,781 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 15, 2025 | Feb 19, 2025 | A · derivative | 5,539 | $0.00 | $0 | 5,539 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 15, 2025 | Feb 19, 2025 | A · derivative | 30,841 | $156.15 | $4,815,822 | 30,841 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 15, 2025 | Feb 19, 2025 | A · derivative | 1,903 | $0.00 | $0 | 1,903 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 15, 2025 | Feb 19, 2025 | A · derivative | 91,277 | $156.15 | $14,252,904 | 91,277 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 15, 2025 | Feb 19, 2025 | A · derivative | 5,632 | $0.00 | $0 | 5,632 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 18, 2025 | Feb 18, 2025 | F | 158 | $156.15 | $24,672 | 21,681 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 18, 2025 | Feb 18, 2025 | F | 94 | $156.15 | $14,678 | 20,022 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 18, 2025 | Feb 18, 2025 | F | 1,602 | $156.15 | $250,152 | 395,923 | No | Form 4 |
| Forminard ElizabethExecutive VP, General Counsel | Feb 18, 2025 | Feb 18, 2025 | F | 307 | $156.15 | $47,938 | 10,014 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 18, 2025 | Feb 18, 2025 | F | 120 | $156.15 | $18,738 | 12,975 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 18, 2025 | Feb 18, 2025 | F | 141 | $156.15 | $22,017 | 16,620.59 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 18, 2025 | Feb 18, 2025 | F | 651 | $156.15 | $101,654 | 170,459 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | Feb 18, 2025 | Feb 18, 2025 | F | 385 | $156.15 | $60,118 | 15,542 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 18, 2025 | Feb 18, 2025 | F | 768 | $156.15 | $119,923 | 5,345 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 18, 2025 | Feb 18, 2025 | F | 200 | $156.15 | $31,230 | 90,836.87 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 18, 2025 | Feb 18, 2025 | S | 403 | $156.15 | Sale −$62,928 | 15,098 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 15, 2025 | Feb 18, 2025 | M | 492 | $0.00 | $0 | 21,839 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 15, 2025 | Feb 18, 2025 | M · derivative | 492 | $0.00 | $0 | 983 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 15, 2025 | Feb 18, 2025 | M | 339 | $0.00 | $0 | 20,116 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 15, 2025 | Feb 18, 2025 | M · derivative | 339 | $0.00 | $0 | 677 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 15, 2025 | Feb 18, 2025 | M | 3,682 | $0.00 | $0 | 397,525 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 15, 2025 | Feb 18, 2025 | M · derivative | 3,682 | $0.00 | $0 | 7,364 | No | Form 4 |
| Forminard ElizabethExecutive VP, General Counsel | Feb 15, 2025 | Feb 18, 2025 | M | 961 | $0.00 | $0 | 10,321 | No | Form 4 |
| Forminard ElizabethExecutive VP, General Counsel | Feb 15, 2025 | Feb 18, 2025 | M · derivative | 961 | $0.00 | $0 | 1,922 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 15, 2025 | Feb 18, 2025 | M | 419 | $0.00 | $0 | 13,095 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 15, 2025 | Feb 18, 2025 | M · derivative | 419 | $0.00 | $0 | 837 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 15, 2025 | Feb 18, 2025 | M | 492 | $0.00 | $0 | 16,761.59 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 15, 2025 | Feb 18, 2025 | M · derivative | 492 | $0.00 | $0 | 983 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 15, 2025 | Feb 18, 2025 | M | 1,594 | $0.00 | $0 | 171,110 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 15, 2025 | Feb 18, 2025 | M · derivative | 1,594 | $0.00 | $0 | 3,188 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | Feb 15, 2025 | Feb 18, 2025 | M | 1,350 | $0.00 | $0 | 15,927 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | Feb 15, 2025 | Feb 18, 2025 | M · derivative | 1,350 | $0.00 | $0 | 2,698 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 15, 2025 | Feb 18, 2025 | M | 1,971 | $0.00 | $0 | 6,113 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 15, 2025 | Feb 18, 2025 | M · derivative | 1,971 | $0.00 | $0 | 3,942 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 15, 2025 | Feb 18, 2025 | M | 607 | $0.00 | $0 | 91,036.87 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 15, 2025 | Feb 18, 2025 | M · derivative | 607 | $0.00 | $0 | 1,212 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 15, 2025 | Feb 18, 2025 | M | 1,029 | $0.00 | $0 | 15,501 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 15, 2025 | Feb 18, 2025 | M · derivative | 1,029 | $0.00 | $0 | 2,056 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 14, 2025 | Feb 18, 2025 | F | 151 | $155.26 | $23,444 | 20,091 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 14, 2025 | Feb 18, 2025 | M | 1,830 | $0.00 | $0 | 21,921 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 14, 2025 | Feb 18, 2025 | F | 574 | $156.71 | $89,952 | 21,347 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 14, 2025 | Feb 18, 2025 | M | 2,910 | $0.00 | $0 | 24,591 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 14, 2025 | Feb 18, 2025 | F | 997 | $156.71 | $156,240 | 23,594 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 14, 2025 | Feb 18, 2025 | M · derivative | 1,830 | $0.00 | $0 | not reported | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 14, 2025 | Feb 18, 2025 | M · derivative | 2,910 | $0.00 | $0 | not reported | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 14, 2025 | Feb 18, 2025 | F | 104 | $155.26 | $16,147 | 19,181 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 14, 2025 | Feb 18, 2025 | M | 850 | $0.00 | $0 | 20,031 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 14, 2025 | Feb 18, 2025 | F | 254 | $156.71 | $39,804 | 19,777 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 14, 2025 | Feb 18, 2025 | M | 1,351 | $0.00 | $0 | 21,373 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 14, 2025 | Feb 18, 2025 | F | 372 | $156.71 | $58,296 | 21,001 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 14, 2025 | Feb 18, 2025 | M · derivative | 850 | $0.00 | $0 | not reported | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 14, 2025 | Feb 18, 2025 | M · derivative | 1,351 | $0.00 | $0 | not reported | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 14, 2025 | Feb 18, 2025 | F | 1,510 | $155.26 | $234,443 | 390,988 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 14, 2025 | Feb 18, 2025 | M | 5,053 | $0.00 | $0 | 396,041 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 14, 2025 | Feb 18, 2025 | F | 2,198 | $156.71 | $344,449 | 393,843 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 14, 2025 | Feb 18, 2025 | M | 19,282 | $0.00 | $0 | 415,205 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 14, 2025 | Feb 18, 2025 | F | 8,386 | $156.71 | $1,314,170 | 406,819 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 14, 2025 | Feb 18, 2025 | M · derivative | 5,053 | $0.00 | $0 | not reported | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 14, 2025 | Feb 18, 2025 | M · derivative | 19,282 | $0.00 | $0 | not reported | No | Form 4 |
| Forminard ElizabethExecutive VP, General Counsel | Feb 14, 2025 | Feb 18, 2025 | F | 215 | $155.26 | $33,381 | 8,776 | No | Form 4 |
| Forminard ElizabethExecutive VP, General Counsel | Feb 14, 2025 | Feb 18, 2025 | M | 851 | $0.00 | $0 | 9,627 | No | Form 4 |
| Forminard ElizabethExecutive VP, General Counsel | Feb 14, 2025 | Feb 18, 2025 | F | 267 | $156.71 | $41,842 | 9,360 | No | Form 4 |
| Forminard ElizabethExecutive VP, General Counsel | Feb 14, 2025 | Feb 18, 2025 | M | 1,352 | $0.00 | $0 | 11,366 | No | Form 4 |
| Forminard ElizabethExecutive VP, General Counsel | Feb 14, 2025 | Feb 18, 2025 | F | 464 | $156.71 | $72,713 | 10,902 | No | Form 4 |
| Forminard ElizabethExecutive VP, General Counsel | Feb 14, 2025 | Feb 18, 2025 | M · derivative | 851 | $0.00 | $0 | not reported | No | Form 4 |
| Forminard ElizabethExecutive VP, General Counsel | Feb 14, 2025 | Feb 18, 2025 | M · derivative | 1,352 | $0.00 | $0 | not reported | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 14, 2025 | Feb 18, 2025 | F | 141 | $155.26 | $21,892 | 11,959 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 14, 2025 | Feb 18, 2025 | M | 1,007 | $0.00 | $0 | 12,966 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 14, 2025 | Feb 18, 2025 | F | 290 | $156.71 | $45,446 | 12,676 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 14, 2025 | Feb 18, 2025 | M | 1,601 | $0.00 | $0 | 14,576 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 14, 2025 | Feb 18, 2025 | F | 457 | $156.71 | $71,616 | 14,119 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 14, 2025 | Feb 18, 2025 | M · derivative | 1,007 | $0.00 | $0 | not reported | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 14, 2025 | Feb 18, 2025 | M · derivative | 1,601 | $0.00 | $0 | not reported | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 14, 2025 | Feb 18, 2025 | F | 152 | $155.26 | $23,600 | 14,866.59 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 14, 2025 | Feb 18, 2025 | M | 1,961 | $0.00 | $0 | 16,827.59 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 14, 2025 | Feb 18, 2025 | F | 558 | $156.71 | $87,444 | 16,269.59 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 14, 2025 | Feb 18, 2025 | M | 3,118 | $0.00 | $0 | 19,738.59 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 14, 2025 | Feb 18, 2025 | F | 889 | $156.71 | $139,315 | 18,849.59 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 14, 2025 | Feb 18, 2025 | M · derivative | 1,961 | $0.00 | $0 | not reported | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 14, 2025 | Feb 18, 2025 | M · derivative | 3,118 | $0.00 | $0 | not reported | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 14, 2025 | Feb 18, 2025 | F | 410 | $155.26 | $63,657 | 166,811 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 14, 2025 | Feb 18, 2025 | M | 4,053 | $0.00 | $0 | 170,864 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 14, 2025 | Feb 18, 2025 | F | 1,348 | $156.71 | $211,245 | 169,516 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 14, 2025 | Feb 18, 2025 | M | 15,465 | $0.00 | $0 | 185,924 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 14, 2025 | Feb 18, 2025 | F | 7,911 | $156.71 | $1,239,733 | 178,013 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 14, 2025 | Feb 18, 2025 | M · derivative | 4,053 | $0.00 | $0 | not reported | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 14, 2025 | Feb 18, 2025 | M · derivative | 15,465 | $0.00 | $0 | not reported | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 14, 2025 | Feb 18, 2025 | F | 507 | $155.26 | $78,717 | 1,272 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 14, 2025 | Feb 18, 2025 | M | 4,014 | $0.00 | $0 | 5,286 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 14, 2025 | Feb 18, 2025 | F | 1,144 | $156.71 | $179,276 | 4,142 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 14, 2025 | Feb 18, 2025 | M | 15,316 | $0.00 | $0 | 20,661 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 14, 2025 | Feb 18, 2025 | F | 6,661 | $156.71 | $1,043,845 | 14,000 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 14, 2025 | Feb 18, 2025 | M · derivative | 4,014 | $0.00 | $0 | not reported | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 14, 2025 | Feb 18, 2025 | M · derivative | 15,316 | $0.00 | $0 | not reported | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 14, 2025 | Feb 18, 2025 | F | 223 | $155.26 | $34,623 | 89,379.87 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 14, 2025 | Feb 18, 2025 | M | 1,530 | $0.00 | $0 | 90,909.87 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 14, 2025 | Feb 18, 2025 | F | 480 | $156.71 | $75,221 | 90,429.87 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 14, 2025 | Feb 18, 2025 | M | 5,837 | $0.00 | $0 | 96,673.87 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 14, 2025 | Feb 18, 2025 | F | 2,393 | $156.71 | $375,007 | 94,280.87 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 14, 2025 | Feb 18, 2025 | M · derivative | 1,530 | $0.00 | $0 | not reported | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 14, 2025 | Feb 18, 2025 | M · derivative | 5,837 | $0.00 | $0 | not reported | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 14, 2025 | Feb 18, 2025 | F | 193 | $155.26 | $29,965 | 13,346 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 14, 2025 | Feb 18, 2025 | M | 1,765 | $0.00 | $0 | 15,111 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 14, 2025 | Feb 18, 2025 | F | 639 | $156.71 | $100,138 | 14,472 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 14, 2025 | Feb 18, 2025 | M · derivative | 1,765 | $0.00 | $0 | not reported | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 14, 2025 | Feb 18, 2025 | M | 2,806 | $0.00 | $0 | 17,904 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 14, 2025 | Feb 18, 2025 | F | 1,015 | $156.71 | $159,061 | 16,889 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 14, 2025 | Feb 18, 2025 | M · derivative | 2,806 | $0.00 | $0 | not reported | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 13, 2025 | Feb 18, 2025 | M | 408 | $0.00 | $0 | 20,242 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 13, 2025 | Feb 18, 2025 | M · derivative | 408 | $0.00 | $0 | 408 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 13, 2025 | Feb 18, 2025 | M | 312 | $0.00 | $0 | 19,285 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 13, 2025 | Feb 18, 2025 | M · derivative | 312 | $0.00 | $0 | 312 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 13, 2025 | Feb 18, 2025 | M | 3,470 | $0.00 | $0 | 392,498 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 13, 2025 | Feb 18, 2025 | M · derivative | 3,470 | $0.00 | $0 | 3,469 | No | Form 4 |
| Forminard ElizabethExecutive VP, General Counsel | Feb 13, 2025 | Feb 18, 2025 | M | 651 | $0.00 | $0 | 8,991 | No | Form 4 |
| Forminard ElizabethExecutive VP, General Counsel | Feb 13, 2025 | Feb 18, 2025 | M · derivative | 651 | $0.00 | $0 | 651 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 13, 2025 | Feb 18, 2025 | M | 411 | $0.00 | $0 | 12,100 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 13, 2025 | Feb 18, 2025 | M · derivative | 411 | $0.00 | $0 | 410 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 13, 2025 | Feb 18, 2025 | M | 447 | $0.00 | $0 | 15,018.59 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 13, 2025 | Feb 18, 2025 | M · derivative | 447 | $0.00 | $0 | 447 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 13, 2025 | Feb 18, 2025 | M | 1,302 | $0.00 | $0 | 167,221 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 13, 2025 | Feb 18, 2025 | M · derivative | 1,302 | $0.00 | $0 | 1,302 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 13, 2025 | Feb 18, 2025 | M | 1,779 | $0.00 | $0 | 1,779 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 13, 2025 | Feb 18, 2025 | M · derivative | 1,779 | $0.00 | $0 | 1,779 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 13, 2025 | Feb 18, 2025 | M | 651 | $0.00 | $0 | 89,602.87 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 13, 2025 | Feb 18, 2025 | M · derivative | 651 | $0.00 | $0 | 651 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 13, 2025 | Feb 18, 2025 | M | 499 | $0.00 | $0 | 13,539 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 13, 2025 | Feb 18, 2025 | M · derivative | 499 | $0.00 | $0 | 499 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Feb 10, 2025 | Feb 12, 2025 | A · derivative | 2,910 | $0.00 | $0 | 2,910 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 10, 2025 | Feb 12, 2025 | A · derivative | 19,282 | $0.00 | $0 | 19,282 | No | Form 4 |
| Swanson James D.EVP, CIO | Feb 10, 2025 | Feb 12, 2025 | A · derivative | 3,118 | $0.00 | $0 | 3,118 | No | Form 4 |
| Schmid TimothyEVP, WW Chair, MedTech | Feb 10, 2025 | Feb 12, 2025 | A · derivative | 2,806 | $0.00 | $0 | 2,806 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 10, 2025 | Feb 12, 2025 | A · derivative | 15,465 | $0.00 | $0 | 15,465 | No | Form 4 |
| Mulholland KristenEVP, Chief HR Officer | Feb 10, 2025 | Feb 12, 2025 | A · derivative | 1,601 | $0.00 | $0 | 1,601 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 10, 2025 | Feb 12, 2025 | A · derivative | 5,837 | $0.00 | $0 | 5,837 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 10, 2025 | Feb 12, 2025 | A · derivative | 15,316 | $0.00 | $0 | 15,316 | No | Form 4 |
| Forminard ElizabethExecutive VP, General Counsel | Feb 10, 2025 | Feb 12, 2025 | A · derivative | 1,352 | $0.00 | $0 | 1,352 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Feb 10, 2025 | Feb 12, 2025 | A · derivative | 1,351 | $0.00 | $0 | 1,351 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 7, 2025 | Feb 11, 2025 | M | 13,015 | $100.06 | $1,302,281 | 13,015 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 7, 2025 | Feb 11, 2025 | S | 13,015 | $153.89 | Sale −$2,002,878 | not reported | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Feb 7, 2025 | Feb 11, 2025 | M · derivative | 13,015 | $100.06 | $1,302,281 | not reported | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 7, 2025 | Feb 11, 2025 | M | 58,504 | $100.06 | $5,853,910 | 213,355 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 7, 2025 | Feb 11, 2025 | F | 47,436 | $153.12 | $7,263,400 | 165,919 | No | Form 4 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Feb 7, 2025 | Feb 11, 2025 | M · derivative | 58,504 | $100.06 | $5,853,910 | not reported | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 7, 2025 | Feb 11, 2025 | M | 32,762 | $100.06 | $3,278,166 | 115,027.87 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 7, 2025 | Feb 11, 2025 | F | 26,076 | $153.12 | $3,992,757 | 88,951.87 | No | Form 4 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Feb 7, 2025 | Feb 11, 2025 | M · derivative | 32,762 | $100.06 | $3,278,166 | not reported | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 7, 2025 | Feb 11, 2025 | M | 126,369 | $100.06 | $12,644,482 | 489,671 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 7, 2025 | Feb 11, 2025 | F | 100,643 | $153.12 | $15,410,456 | 389,028 | No | Form 4 |
| Duato JoaquinCEO and Chairman of the Board | Feb 7, 2025 | Feb 11, 2025 | M · derivative | 126,369 | $100.06 | $12,644,482 | not reported | No | Form 4 |
| Weinberger Mark A | Dec 12, 2024 | Dec 12, 2024 | P | 1,000 | $147.22 | Purchase +$147,220 | 1,000 | No | Form 4 |
| Hewson Marillyn A | Dec 10, 2024 | Dec 12, 2024 | A · derivative | 334.52 | $149.67 | $50,068 | 11,380.22 | No | Form 4 |
| Woods Eugene A. | Dec 10, 2024 | Dec 12, 2024 | A · derivative | 208.79 | $149.67 | $31,250 | 2,804.59 | No | Form 4 |
| Reed John CEVP, Innovative Medicine, R&D | May 1, 2024 | Oct 31, 20244/A | M | 25,255 | $0.00 | $0 | 25,561 | No | Form 4/A |
| Reed John CEVP, Innovative Medicine, R&D | May 1, 2024 | Oct 31, 20244/A | F | 10,984 | $144.59 | $1,588,177 | 14,577 | No | Form 4/A |
| Reed John CEVP, Innovative Medicine, R&D | May 1, 2024 | Oct 31, 20244/A | M · derivative | 25,255 | $0.00 | $0 | 50,510 | No | Form 4/A |
| Wolk Joseph JExec VP, CFO | Oct 17, 2024 | Oct 21, 2024 | G | 68,835 | $0.00 | $0 | not reported | No | Form 4 |
| Wolk Joseph JExec VP, CFO | Oct 17, 2024 | Oct 21, 2024 | G | 68,835 | $0.00 | $0 | 68,835 | No | Form 4 |
| Wolk Joseph JExec VP, CFO | May 22, 2024 | Oct 21, 2024 | G | 55 | $0.00 | $0 | 68,835 | No | Form 4 |
| Davis D Scott | Apr 25, 2024 | Oct 15, 2024 | A · derivative | 1,385.7 | $0.00 | $0 | 15,603.68 | No | Form 4 |
| Hewson Marillyn A | Sep 10, 2024 | Sep 12, 2024 | A · derivative | 302.55 | $165.94 | $50,205 | 10,954.94 | No | Form 4 |
| Woods Eugene A. | Sep 10, 2024 | Sep 12, 2024 | A · derivative | 188.32 | $165.94 | $31,250 | 2,574.47 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Aug 30, 2024 | Sep 3, 2024 | M | 5,635 | $100.06 | $563,838 | 24,608 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Aug 30, 2024 | Sep 3, 2024 | S | 5,635 | $165.06 | Sale −$930,113 | 18,973 | No | Form 4 |
| Decker Robert JVP Corporate Controller | Aug 30, 2024 | Sep 3, 2024 | M · derivative | 5,635 | $100.06 | $563,838 | not reported | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Jul 8, 2024 | Jul 9, 2024 | M | 9,809 | $0.00 | $0 | 24,852 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Jul 8, 2024 | Jul 9, 2024 | F | 5,018 | $147.16 | $738,449 | 19,834 | No | Form 4 |
| Broadhurst VanessaEVP, Global Corp Affairs | Jul 8, 2024 | Jul 9, 2024 | M · derivative | 9,809 | $0.00 | $0 | not reported | No | Form 4 |
| Hewson Marillyn A | Jun 4, 2024 | Jun 6, 2024 | A · derivative | 314.62 | $147.85 | $46,517 | 10,573.38 | No | Form 4 |
| Woods Eugene A. | Jun 4, 2024 | Jun 6, 2024 | A · derivative | 211.36 | $147.85 | $31,250 | 2,368.45 | No | Form 4 |
| Doudna Jennifer A | Apr 25, 2024 | Apr 29, 2024 | A · derivative | 1,385.7 | $0.00 | $0 | 8,081.64 | No | Form 4 |
| Johnson Paula A | Apr 25, 2024 | Apr 29, 2024 | A · derivative | 1,385.7 | $0.00 | $0 | 2,858.55 | No | Form 4 |
| Joly Hubert | Apr 25, 2024 | Apr 29, 2024 | A · derivative | 1,385.7 | $0.00 | $0 | 6,464.15 | No | Form 4 |
| McClellan Mark B. | Apr 25, 2024 | Apr 29, 2024 | A · derivative | 1,385.7 | $0.00 | $0 | 17,867.72 | No | Form 4 |
| Mulcahy Anne M | Apr 25, 2024 | Apr 29, 2024 | A · derivative | 1,385.7 | $0.00 | $0 | 21,470.62 | No | Form 4 |
| Weinberger Mark A | Apr 25, 2024 | Apr 29, 2024 | A · derivative | 1,385.7 | $0.00 | $0 | 9,129.35 | No | Form 4 |
| West Nadja | Apr 25, 2024 | Apr 29, 2024 | A · derivative | 1,385.7 | $0.00 | $0 | 5,093.68 | No | Form 4 |
| Woods Eugene A. | Apr 25, 2024 | Apr 29, 2024 | A · derivative | 1,385.7 | $0.00 | $0 | 2,139.14 | No | Form 4 |
| Adamczyk Darius | Apr 25, 2024 | Apr 29, 2024 | A · derivative | 1,385.7 | $0.00 | $0 | 3,712.7 | No | Form 4 |